We're #hiring a new Senior Accountant in Athens, Attiki. Apply today or share this post with your network.
Cosmos Health Inc.
Pharmaceutical Manufacturing
Chicago , IL 1,799 followers
At Cosmos Health, we are committed to the human needs and we serve healthcare with passion for humanity.
About us
Cosmos Health Inc. is a global healthcare group that was incorporated in 2009 in Chicago, Illinois. Cosmos Health Inc. is engaged in the nutraceuticals sector through its own proprietary lines of products "Sky Premium Life" and "Mediterranation." Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Health is strategically focused on the R&D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&D of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia, and North America. Cosmos Health has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK. More information is available at www.cosmoshealthinc.com and www.skypremiumlife.com.
- Website
-
http://www.cosmoshealthinc.com
External link for Cosmos Health Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Chicago , IL
- Type
- Public Company
- Founded
- 2009
Locations
-
Primary
Get directions
141 West Jackson Blvd.
Chicago , IL 60604, US
Employees at Cosmos Health Inc.
Updates
-
Nasdaq congratulates Cosmos Health Inc. on its strategic acquisition of Cloudscreen®, a next-gen drug repurposing platform, powered by state-of-the-art AI and ML technologies. $COSM #COSM #CosmosHealth #Nasdaq #NasdaqTower Nasdaq #AI #MachineLearning #RND https://cloudscreen.gr/en/
-
-
Cosmos Health Inc. commences the development of Cloudscreen 2.0, the new iteration of its next generation drug repurposing platform, with the integration of cutting-edge AI and Machine Learning technologies. $COSM #COSM #CosmosHealth #AI #MachineLearning https://lnkd.in/dsDpM6Nw
-
Cosmos Health Inc. reposted this
Cosmos Health Inc. receives regulatory approval to sell Sky Premium Life products in the $1.9Bn UAE nutritional supplements market, including Dubai and Abu Dhabi. Has obtained initial purchase orders. $COSM #COSM #CosmosHealth https://lnkd.in/dvNBV6v4
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
accesswire.com
-
Cosmos Health Inc. to receive UK regulatory approval for C-Scrub disinfectant & secures purchase order. Expects to enter into agreements with the NHS, the UK's public healthcare system. Eyes new opportunities in global $36B market $COSM #COSM #CosmosHealth https://lnkd.in/gXd8dyBQ
-
Cosmos Health Inc. receives regulatory approval to sell Sky Premium Life products in the $1.9Bn UAE nutritional supplements market, including Dubai and Abu Dhabi. Has obtained initial purchase orders. $COSM #COSM #CosmosHealth https://lnkd.in/dvNBV6v4
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
accesswire.com
-
Cosmos Health Inc. successfully completes the acquisition of the distribution network owned by Pharmatrade S.A., an established pharmaceutical wholesale company. Expects to increase FY 2024 annual revenue by over $5 million. $COSM #COSM #CosmosHealth https://lnkd.in/d68gvrkz
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
accesswire.com
-
Taglich Brothers publishes first coverage report on Cosmos Health Inc. assigning a Speculative Buy rating with a 12-month price target of $4/share, compared to the share price of $0.83 at the time of publication. Link to report: https://lnkd.in/dbXBpVgH $COSM #COSM #CosmosHealth
Research Report-Update
taglichbrothers.com
-
On Feb 16, 2024, Cosmos Health Inc. CEO Greg Siokas acquired 60,000 $COSM shares in the open market for $49,806 (avg price of $0.8301), demonstrating his strong belief in the Company & unwavering dedication to its continuous development #cosm #cosmoshealth https://lnkd.in/dgyKSbE4
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
accesswire.com
-
This World Cancer Day, Cosmos Health Inc. stands united in the fight against cancer. Together, we can make a difference. #WorldCancerDay $COSM #COSM #CosmosHealth